1722716
SCDG · Clinical drug form groupbotulinum neurotoxin A immune FAB2 / botulinum neurotoxin B immune FAB2 / botulinum neurotoxin C immune FAB2 / botulinum neurotoxin D immune FAB2 / botulinum neurotoxin E immune FAB2 / botulinum neurotoxin F immune FAB2 / botulinum neurotoxin G immune FAB2 Injectable Product
Concept
Cross-maps
Synonyms
No additional synonyms recorded.
Common questions
What is the RxNorm code for botulinum neurotoxin A immune FAB2 / botulinum neurotoxin B immune FAB2 / botulinum neurotoxin C immune FAB2 / botulinum neurotoxin D immune FAB2 / botulinum neurotoxin E immune FAB2 / botulinum neurotoxin F immune FAB2 / botulinum neurotoxin G immune FAB2 Injectable Product?
botulinum neurotoxin A immune FAB2 / botulinum neurotoxin B immune FAB2 / botulinum neurotoxin C immune FAB2 / botulinum neurotoxin D immune FAB2 / botulinum neurotoxin E immune FAB2 / botulinum neurotoxin F immune FAB2 / botulinum neurotoxin G immune FAB2 Injectable Product is coded as 1722716 in RxNorm.
What is RxNorm code 1722716?
1722716 is the RxNorm identifier for botulinum neurotoxin A immune FAB2 / botulinum neurotoxin B immune FAB2 / botulinum neurotoxin C immune FAB2 / botulinum neurotoxin D immune FAB2 / botulinum neurotoxin E immune FAB2 / botulinum neurotoxin F immune FAB2 / botulinum neurotoxin G immune FAB2 Injectable Product. It is included in the current monthly NLM RxNorm release.
What term type is RxCUI 1722716?
1722716 is a SCDG (Clinical drug form group) in RxNorm.
What is the UMLS mapping for 1722716?
1722716 maps to UMLS C4059126.